Form 4: SpringWorks Therapeutics Director Alan Fuhrman Receives Stock Grant

Director Alan Fuhrman of SpringWorks Therapeutics receives a grant of restricted stock units (RSUs) and disposes of common stock.

Summary

• On May 14, 2025, Alan Fuhrman, a director at SpringWorks Therapeutics, received 10,060 restricted stock units (RSUs).
• These RSUs were granted under the company's Amended and Restated Non-Employee Director Compensation Policy.
• The RSUs will vest fully on the earlier of May 14, 2026, or the date of the next annual meeting of stockholders, contingent upon continued service.
• Fuhrman also disposed of 24,727 shares of common stock.
• Following these transactions, Fuhrman beneficially owns 24,727 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects standard compensation practices. The grant of RSUs is a positive sign of aligning director interests with shareholders, but the disposal of shares is a neutral event as it is not specified why the shares were disposed of.

Future Outlook

The RSUs will vest on the earlier of May 14, 2026, or the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.

Industry Context

This filing is a routine disclosure of equity compensation to a company director, which is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Stakeholder Impact

• The equity grant aligns the director's interests with those of the shareholders.
• The equity grant is part of the director's compensation.

Key Dates

Keywords

SpringWorks Therapeutics, Director, Alan Fuhrman, RSU, Restricted Stock Units, Equity Grant, Beneficial Ownership, Form 4